Drug Development Ai

Phased vs. Federated: Choosing an AI Integration Strategy for Pharma R&D

Pharmaceutical R&D organizations must strategically choose between a phased AI integration approach, building capabilities sequentially, or a federated governance model, enabling decentralized innovation with central oversight, to effectively leverage AI's potential.